Russia says its Ebola vaccine 'effective' in initial tests

February 15, 2016

Russia's health minister said Monday that an Ebola vaccine developed by the country over the last 15 months had shown encouraging results and would undergo further testing in West Africa.

"Phases one and two of testing were managed in Russia with volunteers and showed that the was very effective," minister Veronika Skovortsova told reporters in Geneva.

Skovortsova said the vaccine GamEvac-Combi, developed at a government vaccine research institute, would now be put to additional tests in Guinea.

The West African countries of Guinea, Liberia and Sierra Leone have been hardest-hit by the worst-ever Ebola outbreak which has killed more than 11,300 people since December 2013.

The Russian minister made the comments ahead of a meeting Tuesday with the UN's World Health Organization chief Margaret Chan.

The WHO is hoping to study the Russian findings before giving an opinion on the new vaccine.

WHO spokeswoman Fadela Chaib told AFP in an email that the UN agency was aware that "Russian regulatory authorities had approved an anti-Ebola vaccine.

"The WHO secretariat is actively hoping for the possibility to study the data," regarding the performance of the vaccine, she added.

According to the Russian official, the preliminary testing showed limited side effects in isolated cases, including headaches and slight body temperature rises.

Russian officials at the briefing who led the testing said the sequential injections led to surge in antibody production among the trial subjects.

So far no approved vaccine or treatment for Ebola exists and the WHO has authorised the fast-track development of drugs.

Explore further: Putin claims Russia has developed Ebola vaccine

Related Stories

Ebola vaccine shows 'promising' results: WHO

July 31, 2015

Preliminary results of tests on an Ebola vaccine to be published later Friday in British science magazine The Lancet have shown "promising" results, World Health Organization Director-General Margaret Chan said.

WHO yet to take Canada's experimental Ebola vaccine

October 9, 2014

Doses of a prototype Ebola vaccine developed by Canada remain in the country even though they were offered to the World Health Organization nearly two months ago, the health minister said Thursday.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.